Drug-induced hypersensitivity syndrome: Recent advances in the diagnosis, pathogenesis and management

Chemical Immunology and Allergy

Volumn 97, Issue , 2012, Pages 122-138

  Shiohara, Tetsuo ^a   Kano, Yoko ^a   Takahashi, Ryo ^a   Ishida, Tadashi ^a   Mizukawa, Yoshiko ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN; LAMOTRIGINE; MEXILETINE; MINOCYCLINE; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; SALAZOSULFAPYRIDINE; VIRUS ANTIGEN; ZONISAMIDE;

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CROSS REACTION; CYTOMEGALOVIRUS; DIAGNOSTIC VALUE; DISEASE COURSE; DRESS SYNDROME; EPSTEIN BARR VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; LABORATORY DIAGNOSIS; LYMPHOCYTE TRANSFORMATION TEST; MEMORY CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RISK FACTOR; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS; VIRUS PATHOGENESIS; VIRUS REACTIVATION;

ADRENAL CORTEX HORMONES; ANTICONVULSANTS; AUTOIMMUNE DISEASES; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; EOSINOPHILIA; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 84926075581     PISSN: 16602242     EISSN: 16622898     Source Type: Book Series    
DOI: 10.1159/000335624     Document Type: Article

References (43)

1. Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-1285.
2. Merritt HH, Putnam TJ: Sodium diphenylhydantoinate in the treatment of convulsive disorders. JAMA 1938;111:1068-1073.
3. Chaiken BH, Goldberg BI, Segal JP: Dilantin hypersensitivity: report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis. N Engl J Med 1950;242:897-898.
4. Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15:250-257.
5. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-1112.
6. Tohyama H, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:1113-1117.
7. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K: The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156:1083-1084.
8. Shiohara T, Inaoka M, Kano Y: Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006;55:1-8.
9. Hashimoto K, Yasukawa M, Tohyama M: Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003;3:255-260.
10. Peynére H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D: Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155:422-428.
11. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC: Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156:609-611.
12. Shiohara T, Takahashi R, Kano Y: Drug-induced hypersensitivity syndrome and viral reactivation; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 251-266.
13. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Spielberg SP: Familiar occurrence of hypersensitivity to phenytoin. Am J Med 1991;91:631-634.
14. Vittorio CC, Muglia JJ: Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-2290.
15. Stanley J, Fallon-Pellicci V: Phenytoin hypersensitivity reaction. Arch Dermatol 1978;114:1350-1353.
16. Hari Y, Frutig-Schnyder K, Humi M, Yawalkar N, Zanni MP, Schnyder B, Kappeler A, von Greyerz S, Braathen LR, Pichler WJ: T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001;31: 1398-1408.
17. Kano Y, Shiohara T: The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009;29:481-501.
18. Kano Y, Ishida T, Hirahara K, Shiohara T: Visceral involvements and long-term sequelae in druginduced hypersensitivity syndrome. Med Clin North Am 2010;94:743-759.
19. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T: Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009;182: 8071-8079.
20. Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, Mockenhaupt M, Fagot JP, Roujeau JC: Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational casecontrol study (EuroSCAR). Br J Dermatol 2007; 157:989-996.
21. Horneff G, Lenard HG, Wahn V: Severe adverse reaction to carbamazepine: significance of humoral and cellular reactions to the drug. Neuropediatrics 1992;23:272-275.
22. Shiohara T, Kurata M, Mizukawa Y, Kano Y: Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy. Allergol Int 2010;59: 333-343.
23. Kano Y, Inaoka M, Shiohara T: Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004;140: 183-188.
24. Hogg RJ, Sawyer M, Hecox K, Eigenbrodt E: Carbamazepine-induced acute tubulointestinal nephritis. J Pediatr 1981;83:830-832.
25. Imai H, Nakamoto Y, Hirokawa M, Akihama T, Miura A: Carbamazepin-induced granulomatous necrotizing angiitis with acute renal failure. Nephron 1989;51:405-408.
26. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B: Druginduced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003; 148:1032-1034.
27. Kano Y, Hirahara K, Sakuma K, Shiohara T: Several herpesviruses can reactivate in a severe druginduced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006;155:301-306.
28. Aihara M, Sugita Y, Takahashi S, Nagatani T, Arata S, Takeuchi K, Ikezawa Z: Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001;144:1231-1234.
29. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004;59:809-820.
30. Kano Y, Hirahara K, Mitsuyama T, Takahashi R, Shiohara T: Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 2007;62:1439-1444.
31. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT: HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005;102:4134-4139.
32. Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P: Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010;2:46-62.
33. Zhao DM, Thomton AM, DiPaolo RJ, Shevach EM: Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006;107:3925-3932.
34. Aota N, Shiohara T: Viral connection between drug rashes and autoimmune disease: how autoimmune responses are generated after resolution of drug rashes. Autoimmun Rev 2009;8:488-494.
35. Sommers LM, Schoene RB: Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus. Arch Intern Med 2002;162:1190-1192.
36. Seino Y, Yamauchi M, Hirai C, Okumura A, Kondo K, Yamamoto M, Okazaki Y: A case of fulminant type 1 diabetes associated with mexiletine hypersensitivity syndrome. Diabet Med 2004;21:1156-1157.
37. Chiou CC, Chung WH, Hung SI, Ynag LC, Hong HS: Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 2006;54: S14-S17.
38. Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, Cowen EW: Minocyclineinduced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009;145:63-66.
39. Kano Y, Sakuma K, Shiohara T: Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome. Br J Dermatol 2007;156:1061-1063.
40. Aota N, Hirahara K, Kano Y, Fukuoka T, Yamada A, Shiohara T: Systemic lupus erythematosus presenting with Kikuchi-Fujimoto's disease as a long-term sequela of drug-induced hypersensitivity syndrome. A possible role of Epstein-Barr virus reactivaton. Dermatology 2009;218:275-277.
41. Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J: Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004;172: 1287-1294.
42. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA: EBV and systemic lupus erythematosus: a new perspective. J Immunol 2005;174:6599-6607.
43. Asano Y, Kagawa H, Kano Y, Shiohara T: Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol 2009;145:1030-1036.